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Lectin-like proteins from eight South African medicinal plant species were examined for prostaglandin synthesis inhibitory activity. Lectins
were isolated and partially purified from plant species used mainly for inflammatory ailments by traditional healers and tested for anti-
inflammatory activity in an in vitro assay using the cyclooxygenase assay (COX-1). Of the eight species tested, two, Eucomis autumnalis and
Combretum mkhuzense exhibited high COX-1 activity (80–90%) in vitro. The possible contribution of plant lectins in the anti-inflammatory
properties of traditional herbal remedies is discussed.
© 2006 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Anti-inflammatory; Cyclooxygenase; Lectins; Medicinal plants1. Introduction
The complex processes of inflammation involve biosynthe-
sis of prostaglandins that are responsible for the sensation of
pain. The inhibitors of prostaglandin biosynthesis are consid-
ered as potential anti-inflammatory agents. Prostaglandin endo-
peroxide synthetase (cyclooxygenase, EC 1.14.99.1) catalyzes
the first step in the formation of prostaglandins and thrombox-
anes, the conversion of arachidonic acid to prostaglandin endo-
peroxides G and H. This is the target enzyme of nonsteroidal
anti-inflammatory drugs (NSAIDs) such as aspirin and ibupro-
fen. Due to the unwelcome ulcerogenic and renal side effects
of non-steroidal anti-inflammatory agents discovery of new
natural nontoxic substances with the anti-inflammatory proper-
ties remains topical.
Current advances in ethnopharmacology have provided new
insights for the substitution of non-steroidal synthetical anti-
inflammatory drugs by naturally occurring inhibitors of cyclo-⁎ Corresponding author.
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doi:10.1016/j.sajb.2006.02.005oxygenase (COX). Avariety of plant extracts used as traditional
medicines to treat inflammatory disorders strongly suggests that
medicinal plants are the major source of important phytochem-
icals. They are synthesized in the secondary metabolism of the
plant and known by their active substances, for example, the
phenolic compounds which are part of the essential oils, as well
as in tannin, saponins and bufadienolides (Jäger et al., 1996;
Taylor and Van Staden, 2001; Sparg et al., 2002).
During the last decade much attention has been given to the
pharmacological effects of natural peptides and proteins,
amongst them lectins. Lectins are important physiologically
active ingredients and potent exogenous biological signals in
the diet (Pusztai and Bardocz, 1997). They selectively bind
glycoconjugates and reveal regulatory properties at the cellular
level by activating immune cells, inducing apoptosis or modu-
lating their cytokine secretion, therefore they effectively func-
tion as biological response modifiers (Gabius, 2001). The
respective plant lectins exhibit internal activities by interacting
with endogenous enzymes such as glycosidase (Einhoff et al.,
1986; Freier and Rudiger, 1987) and phosphatase (Rudiger and
Bartz, 1993) in a carbohydrate-, ion strength- or pH-dependent
manner. Moreover, lectins may not only bind enzymes but also
modify their activities (Lorenc-Kubis et al., 1981; Saito et al.,ts reserved.
662 M. Gaidamashvili, J. van Staden / South African Journal of Botany 72 (2006) 661–6631982; Brechtel et al., 2001; Karpunina et al., 2000) thus have
considerable impact on their biological functions.
The primary effects and the potency of lectins as biological
signals are the direct result of their specific chemical reactivity
with glycosylated biomolecules. Consequently, cyclooxygenase
is a membrane-bound glycoprotein (Johnson et al., 1983) and
might be a potent target for lectins. Despite considerable infor-
mation on anti-inflammatory pharmacological effects of plant
secondary metabolites, to date no mention has been made about
possible anti-inflammatory properties of plant lectins. In addi-
tion, the plant parts utilized in traditional healing are mainly
storage organs including tubers, bulbs, rhizomes and bark,
which are rich sources of storage proteins and lectins apart from
other secondary metabolites.
Therefore, in this study, using an in vitro assay we evaluated
the cyclooxygenase inhibitory activity of lectins from South
African medicinal plants used in traditional healing of inflam-
mation. Our results suggest that some lectins have good po-
tential as anti-inflammatory agents exhibiting COX-inhibitory
activity in high levels.
2. Materials and methods
2.1. Plant material
Experimental plants were grown in The University of
KwaZulu-Natal Natal Botanical Garden under shade house
conditions. Botanical names and plant parts used are given in
Table 1 as identified by the Herbarium of the University of
KwaZulu-Natal. All plants except Combretum mkhuzense were
used fresh. C. mkhuzense bark was dried in an oven at 50 °C and
stored at room temperature until extraction.
2.2. Purification of lectins
Lectin-like proteins were isolated and partially purified as
previously outlined (Gaidamashvili and Van Staden, 2002).
Briefly, plant parts were homogenized at the (w/v) ratio of 1 to 5
in buffer containing 0.15 M NaCl, 50 mM NaH2PO4 (pH 7.4).
Proteins were salted out using solid ammonium sulfate to give
80% (w/v) final saturation followed by overnight dialysis
against the buffer containing 0.15 M NaCl, 50 mM NaH2PO4
(pH 7.4). Lectin-like proteins were purified by affinity chroma-
tography on immobilized erythrocytes on a Sephadex-G25
column. All steps were conducted in ice-cold conditions.Table 1
Cyclooxygenase inhibitory activity of plant agglutinins
Plant name Voucher number
Bulbine frutescens L. NU Herb. 985/10
Combretum mkhuzense Loeff. Nelspruit Bot. Garden 142/90
Crinum moorei Hook f. NU Herb. 1189/2
Drimia robusta Bak. NU Herb. 1082/11
Eucomis autumnalis Mill. NU Herb. 1088/5
Hypoxis hemerocallidea Fish and Mey NU Herb. 1230/10
Merwilla natalensis Planch. NU Herb. 1189/2
Tulbaghia violacea Harv. NU Herb. 1047/2
NU Herb.=University KwaZulu-Natal Herbarium, Pietermaritzburg.Lectins were detected by agglutination using trypsin-treated
rabbit erythrocytes (Lis and Sharon, 1972). Heamagglutination
assays were carried out in 96 well microtiter plates in a final
volume of 100 μl containing 50 μl serially diluted lectin solu-
tion and 50 μl of 2% erythrocyte suspension. Agglutination was
assessed visually after 30 min at room temperature. Proteins
were determined by the method of Bradford (1976) using bo-
vine serum albumin as a standard.
2.3. Cyclooxygenase assay
Cyclooxygenase assay was performed according to the
method of White and Glassman (1974) as modified by Jäger
et al. (1996).
3. Results and discussion
The results of the screening of lectin-like proteins for cyclo-
oxygenase inhibition are shown in Table 1. Generally, all plants
exhibited inhibitory activity except Crinum moorei and Drimia
robusta. The idomethacin standard inhibited cyclooxygenase to a
level of 59±1.8%. The highest activity was obtained with protein
extracts of Eucomis autumnalis followed by C. mkhuzense with
88% and 82% inhibition respectively. In contrast, low levels of
inhibition were found with Bulbine frutescens, Hypoxis hemer-
ocalloidea, Merwilla natalensis and Tulbaghia violacea.
Effects of aqueous and methanolic extracts of Hypoxis
hemerocallidea, M. natalensis and E. autumnalis on COX-
inhibitory activity were investigated previously and some anti-
inflammatory activities were reported. Ojewole (2002) showed
that a methanolic extract ofH. hemerocallidea produced relatively
greater and more pronounced anti-inflammatory effect than the
aqueous extract. Similarly, pharmacological and phytochemical
screening of M. natalensis revealed that dichloromethane and
hexane extracts resulted in good inhibition against both COX-1
and COX-2 owing to the presence of saponins and bufadienolides
within the bulbs (Sparg et al., 2002). Our findings indicated
relatively low COX-inhibitory activity of H. hemerocallidea and
M. natalensis lectins. Jäger et al. (1996) reported that ethanolic
extracts of E. autumnalis caused higher inhibition than aqueous
extracts when tested in an in vitro assay for cyclooxygenase
inhibitors. However, E. autumnalis lectin solution showed high
COX inhibitory activity compared to other plant species tested. To
our knowledge, no COX-inhibitory activities were reported by the
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ygenase activity, it was observed that in almost all cases aque-
ous extracts were less active when compared to that of
compounds obtained with organic solvents (Jäger et al., 1996;
Taylor and Van Staden, 2001). Nevertheless, the principle way
of administration of plant remedies used in traditional healing
are oral decoctions of dry/fresh plants or ground powders that
are taken as a snuff and subsequently distributed over the nasal
mucosa or digestive tract. Most probably, all these ways can
basically be viewed as an uptake of “aqueous extracts” that are
much similar to protein solutions in saline.
Inhibition of cyclooxygenase by plant lectins are of interest
and provide new insights into the COX pathway of interrupting
arachidonate metabolism. All non-steroidal anti-inflammatory
agents in clinical use have been shown to inhibit COX leading
to a marked reduction in PG synthesis. The inhibition by aspirin
is due to irreversible acetylation of the cyclooxygenase compo-
nent of COX, leaving the peroxidase activity unaffected. In
contrast, NSAIDs like indomethacin or ibuprofen inhibit COX
reversibly by competing with the substrate, arachidonic acid for
the active site of the enzyme.
Advances in cDNA sequencing showed that COX-1 is a
membrane-bound glycoprotein (Johnson et al., 1983) and it has
three potential sites for N-glycosylation, two of them in the
amino-terminal half of the molecule (DeWitt and Smith, 1988).
A promising outcome of selective interaction of lectins with
cyclooxygenase appear to be that the way of inhibition of PG
production is ultimately different and based on binding of lectin
to glycosylated moieties of cyclooxygenase thereby modifying
its activity. Apparently, it may not lead to the principal side
effects associated with use of standard NSAIDs such as gastro-
intestinal inhibition and ulcers. In this respect, use of lectins in
clinical–medical applications offers much promise. On the
other hand, glycosylation is required for expression of both,
cyclooxygenase and peroxidase activities of the enzyme (Otto
et al., 1993) and it is not evident whether such interaction may
create any other unwelcome side effects.
At present it is not possible to provide a comprehensive
explanation for the mechanism of lectin–COX interaction. To
our knowledge to date no lectin-like proteins were reported to
inhibit cyclooxygenase activity. The primary results prove to be
promising; however, more specific approaches may require
consideration of protein–protein interactions in vitro. The ap-
proach will operate on the usual assumption and requirement
that the potential remedy reaches the target enzyme in adequate
concentration, unmodified or as an active metabolite. Therefore,
further refinement is necessary to evaluate whether plant lectins
could translate automatically into clinical benefit.
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